Urology · San Antonio, TX
NPI
1881038412
Since 2013
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3327 Research Plz Ste 403
San Antonio, TX, 78235
Phone (210) 337-6228
Groups this clinician bills Medicare through
Medicare paid, 2024
$216K
6,384 services
Medicare patients, 2024
567
Average age 76
Drug cost, 2024
$5.8M
5,040 prescriptions
Company payments, 2025
$195K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose de la Cerda III was code 87798 (infectious agent detection by dna/rna), 996 times for 60 patients. In total Jose de la Cerda III billed 6,384 services in 79 codes, and Medicare paid $216K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87798 Infectious Agent Detection by DNA/RNA | Office | 996 | 60 | $34.00 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 411 | 316 | $11.86 | $4,872 |
| 81001 Clinical Chemistry | Office | 359 | 267 | $3.09 | $1,108 |
| 99214 Office E&M - Established | Office | 314 | 241 | $87.87 | $28K |
| 36415 Venipuncture Blood Collection | Office | 270 | 225 | $8.65 | $2,336 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 266 | 45 | $42.57 | $11K |
| 84153 Clinical Chemistry | Office | 184 | 149 | $18.02 | $3,316 |
| 51798 Ultrasound - Nonspecific | Office | 176 | 147 | $7.17 | $1,263 |
| 99213 Office E&M - Established | Office | 149 | 124 | $59.11 | $8,808 |
| 87640 Infectious Agent Detection by DNA/RNA | Office | 83 | 60 | $34.00 | $2,822 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 83 | 60 | $34.00 | $2,822 |
| 87653 Infectious Agent Detection by DNA/RNA | Office | 83 | 60 | $34.00 | $2,822 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 74 | 72 | $69.39 | $5,135 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 72 | 12 | $142.51 | $10K |
| 99204 Office E&M - New | Office | 57 | 57 | $104.21 | $5,940 |
By year: 2022 $291K for 10,474 services; 2023 $198K for 5,906 services; 2024 $216K for 6,384 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 996 | 60 | $34.00 | $34K |
| 81001 Clinical Chemistry | 359 | 267 | $3.09 | $1,108 |
| 36415 Venipuncture Blood Collection | 270 | 225 | $8.65 | $2,336 |
| 84153 Clinical Chemistry | 184 | 149 | $18.02 | $3,316 |
| 87653 Infectious Agent Detection by DNA/RNA | 83 | 60 | $34.00 | $2,822 |
| 87481 Infectious Agent Detection by DNA/RNA | 83 | 60 | $34.00 | $2,822 |
| 87640 Infectious Agent Detection by DNA/RNA | 83 | 60 | $34.00 | $2,822 |
| 84403 Clinical Chemistry | 46 | 31 | $25.29 | $1,163 |
| 80048 Clinical Chemistry | 44 | 33 | $8.29 | $365 |
| 85025 Blood Count | 25 | 18 | $7.61 | $190 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose de la Cerda III prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,176 prescriptions and refills. In total Jose de la Cerda III wrote 5,040 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,176 | 3,334 | 414 | $12K |
| Finasteride Generic | 985 | 2,922 | 333 | $11K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 290 | 826 | 107 | $7,911 |
| Myrbetriq Mirabegron | 274 | 594 | 99 | $266K |
| Erleada Apalutamide | 185 | 185 | 26 | $2.7M |
| Acetaminophen-Codeine Acetaminophen With Codeine | 138 | 138 | 129 | $981 |
| Solifenacin Succinate Generic | 134 | 381 | 67 | $6,906 |
| Gemtesa Vibegron | 132 | 325 | 48 | $155K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 121 | 315 | 40 | $2,441 |
| Orgovyx Relugolix | 119 | 119 | 20 | $370K |
| Abiraterone Acetate Generic | 115 | 115 | 12 | $194K |
| Xtandi Enzalutamide | 112 | 116 | 14 | $1.5M |
| Oxybutynin Chloride Generic | 112 | 204 | 68 | $1,040 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 107 | 107 | 85 | $1,366 |
| Estradiol Generic | 83 | 238 | 40 | $6,339 |
Brand drugs: 946 claims; generic drugs: 4,094 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose de la Cerda III $195K ($190K in general payments such as food, travel and fees and $5,649 for research) from 23 companies. The largest payer was Janssen Biotech, Inc. with $108K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 159 | $108K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 18 | $34K |
| Sumitomo Pharma America, Inc. 4506.T | 14 | $16K |
| Janssen Scientific Affairs, LLC JNJ | 3 | $8,095 |
| Dendreon Pharmaceuticals LLC | 10 | $8,045 |
| Astellas Pharma US Inc 4503.T | 13 | $6,932 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $5,707 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $2,953 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $2,674 |
| Ferring Pharmaceuticals Inc. | 1 | $1,518 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.